Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-25-003694
Filing Date
2025-05-15
Accepted
2025-05-15 15:23:41
Documents
58
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR MAR 2025 bioregenx_i10q-033125.htm   iXBRL 10-Q 654846
2 CERTIFICATION bioregenx_ex3100.htm EX-31 7071
3 CERTIFICATION bioregenx_ex3200.htm EX-32 3217
  Complete submission text file 0001683168-25-003694.txt   4339791

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE brgx-20250331.xsd EX-101.SCH 41994
5 XBRL CALCULATION FILE brgx-20250331_cal.xml EX-101.CAL 45600
6 XBRL DEFINITION FILE brgx-20250331_def.xml EX-101.DEF 204696
7 XBRL LABEL FILE brgx-20250331_lab.xml EX-101.LAB 300975
8 XBRL PRESENTATION FILE brgx-20250331_pre.xml EX-101.PRE 270679
60 EXTRACTED XBRL INSTANCE DOCUMENT bioregenx_i10q-033125_htm.xml XML 520220
Mailing Address 7407 ZIEGLER ROAD CHATTANOOGA TN 37421
Business Address 7407 ZIEGLER ROAD CHATTANOOGA TN 37421 (866) 770-4067
BIOREGENX, INC. (Filer) CIK: 0001593184 (see all company filings)

EIN.: 462836541 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56345 | Film No.: 25951909
SIC: 7370 Services-Computer Programming, Data Processing, Etc.
(CF Office: 06 Technology)